Income Statement - Amylyx Pharmaceuticals, Inc. (AMLX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 87.37 | 380.79 | 22.23 | 0.29 | 0.65 | 1.43 |
| Cost of revenue | 0.53 | 42.16 | 25.44 | 2.99 | 0.05 | 24.59 | 11.90 |
| Gross profit | -0.53 | 45.22 | 355.35 | 19.24 | 0.29 | -23.94 | -10.47 |
| Total operating expenses | 152.77 | 359.95 | 316.54 | 220.58 | 82.69 | 15.06 | 13.55 |
| Operating income | -153.29 | -314.73 | 38.80 | -201.34 | -82.69 | -39.01 | -13.55 |
| Non-operating income (net) | 8.60 | 12.60 | 15.50 | 3.74 | -5.24 | -3.28 | -0.16 |
| Income before tax | -144.69 | -302.14 | 54.30 | -197.60 | -87.93 | -42.28 | -13.72 |
| Income tax expense | 0.05 | -0.39 | 5.03 | 0.77 | -0.05 | 2.56 | 1.10 |
| Net income | -144.74 | -301.74 | 49.27 | -198.38 | -87.88 | -42.28 | -14.82 |
Show Quarterly Income Statement
Income Statement - Amylyx Pharmaceuticals, Inc. (AMLX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.67 | 0.42 | -1.02 | 88.64 | 108.45 | 102.69 | 98.22 | 71.43 | 21.89 | 0.35 | 0.00 | 0.00 | 0.00 | 0.29 | 0.00 | 0.00 | 0.35 |
| Cost of revenue | 0.10 | 0.11 | 19.86 | 0.14 | 0.00 | 0.16 | 0.81 | 7.63 | 116.41 | 9.36 | 5.22 | 5.58 | 5.28 | 2.82 | 0.17 | 0.11 | 0.04 | 0.02 | 12.85 | 0.01 | 0.01 | 5.01 |
| Gross profit | -0.10 | -0.11 | -19.86 | -0.14 | 0.00 | -0.67 | -0.39 | -8.65 | -27.76 | 99.09 | 97.48 | 92.64 | 66.15 | 19.06 | 0.17 | -0.11 | -0.04 | -0.02 | -12.57 | -0.01 | -0.01 | -4.66 |
| Total operating expenses | 43.78 | 36.50 | 16.17 | 42.72 | 37.80 | 39.99 | 75.27 | 44.79 | 94.37 | 97.16 | 78.76 | 72.44 | 68.20 | 63.66 | 54.85 | 54.25 | 47.81 | 28.32 | 22.92 | 18.59 | 12.87 | 8.59 |
| Operating income | -43.78 | -36.61 | -36.03 | -42.86 | -37.80 | -40.65 | -75.66 | -53.44 | -122.13 | 1.93 | 18.72 | 20.20 | -2.05 | -44.59 | -54.68 | -54.25 | -47.81 | -28.32 | -22.92 | -18.59 | -12.87 | -8.59 |
| Non-operating income (net) | 2.50 | 3.65 | 1.64 | 1.41 | 1.90 | 2.47 | 2.96 | -19.27 | 3.58 | 4.54 | 3.69 | 3.81 | 3.46 | 2.47 | 0.80 | 0.36 | 0.11 | -0.03 | -0.22 | -3.34 | -1.66 | 0.00 |
| Income before tax | -41.28 | -32.95 | -34.39 | -41.44 | -35.91 | -38.18 | -72.70 | -72.70 | -118.55 | 6.48 | 22.41 | 24.01 | 1.40 | -42.13 | -53.88 | -53.89 | -47.70 | -28.34 | -23.14 | -21.92 | -14.52 | -8.59 |
| Income tax expense | 0.05 | -0.64 | -72.70 | 0.24 | 1.75 | 1.52 | 1.93 | -0.17 | 0.58 | -0.13 | 0.17 | 0.15 | -0.03 | 0.22 | 3.33 | 1.65 | 0.00 | |||||
| Net income | -41.28 | -33.00 | -34.39 | -41.44 | -35.91 | -37.55 | -72.70 | -72.70 | -118.79 | 4.73 | 20.89 | 22.07 | 1.57 | -42.70 | -53.76 | -54.07 | -47.85 | -28.34 | -23.14 | -21.92 | -14.52 | -8.59 |